Achieve Life Sciences Announces Pricing Of $124.2M Registered Direct Offering Of 13,086,151 Shares At $4.585/Share; Concurrent Private Placement Company To Issue Unregistered Warrants To Purchase 13,086,151 Shares At $4.906/Share
Benzinga Newsdesk - Feb 29, 2024, 8:05AM